Clinical trial
Study of Intralesional Injection of M4N in Patients With Refractory Malignant…
NCT00057512 · Erimos Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00057512 |
|---|---|
| Title | Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck |
| Official title | Open-Label Phase 1 Dose Escalation Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck |
| Lead sponsor | Erimos Pharmaceuticals, Industry |
| Collaborators | Duke University Medical University of South Carolina |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Neoplasms |
| Intervention type | Drug |
| Interventions | M4N |
| Enrollment | 9 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Apr 4, 2003 |
| Last update posted | Feb 23, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: